Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 1
2011 3
2012 3
2013 3
2014 2
2016 2
2017 7
2018 1
2019 1
2020 3
2021 4
2022 9
2023 8
2024 7
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Cope AP, Jasenecova M, Vasconcelos JC, Filer A, Raza K, Qureshi S, D'Agostino MA, McInnes IB, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga T, Toes R, Georgiou E, Kelly J, Murphy C, Prevost AT; APIPPRA study investigators. Cope AP, et al. Lancet. 2024 Mar 2;403(10429):838-849. doi: 10.1016/S0140-6736(23)02649-1. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364839 Free article. Clinical Trial.
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study.
Kristensen LE, Ng KJ, Ngantcha M, Morel J, Lubrano E, Tillett W, Alten R, Chandran V, Martinez Ferrer À, Zhu B, Kennedy D, Holzkämper T, Gullick N, Kronbergs A, Fakhouri W, de la Torre I, McGonagle DG. Kristensen LE, et al. Among authors: gullick n. RMD Open. 2024 Sep 20;10(3):e004318. doi: 10.1136/rmdopen-2024-004318. RMD Open. 2024. PMID: 39306343 Free PMC article.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Campanholo CB, Maharaj AB, Corp N, Bell S, Costa L, de Vlam K, Gullick NJ, Khraishi M, Kishimoto M, Palmou-Fontana N, Reddy S, Scarpa R, Vega L, Duarte GV, Zisman D, van der Windt DA, Duruoz MT, Ogdie A. Campanholo CB, et al. Among authors: gullick nj. J Rheumatol. 2023 Mar;50(3):426-432. doi: 10.3899/jrheum.220310. Epub 2022 Nov 1. J Rheumatol. 2023. PMID: 36319003 Free article.
Co-morbidities in established rheumatoid arthritis.
Gullick NJ, Scott DL. Gullick NJ, et al. Best Pract Res Clin Rheumatol. 2011 Aug;25(4):469-83. doi: 10.1016/j.berh.2011.10.009. Best Pract Res Clin Rheumatol. 2011. PMID: 22137918 Review.
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study.
Rodziewicz M, Dyball S, Lunt M, McDonald S, Sutton E, Parker B, Bruce IN; British Isles Lupus Assessment Group Biologics Register (BILAG-BR) consortium. Rodziewicz M, et al. Lancet Rheumatol. 2023 May;5(5):e284-e292. doi: 10.1016/S2665-9913(23)00091-7. Lancet Rheumatol. 2023. PMID: 38251591 Free article.
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.
Worth C, Al-Mossawi MH, Macdonald J, Fisher BA, Chan A, Sengupta R, Packham J, Gaffney K, Gullick N, Cook JA, Corn TH, Teh J, Machado PM, Taylor PC, Bowness P. Worth C, et al. Among authors: gullick n. Lancet Rheumatol. 2024 Aug;6(8):e537-e545. doi: 10.1016/S2665-9913(24)00099-7. Epub 2024 Jun 25. Lancet Rheumatol. 2024. PMID: 38942047 Free article. Clinical Trial.
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literature.
Nagra D, Song K, Odia J, Wincup C, Mahto A, Rosa C, Kasavkar G, Adas MA, Yang Z, Russell MD, Bechman K, Blake T, Banerjee S, Gullick N, Galloway JB. Nagra D, et al. Among authors: gullick n. Rheumatology (Oxford). 2025 Jun 30:keaf356. doi: 10.1093/rheumatology/keaf356. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40587102
The use of combination advanced therapies in psoriatic arthritis: results from a UK multi-centre audit.
Jethwa H, Gudu T, Coates LC, Helliwell PS, Tillett W, Abuelmagd A, Andev RS, Ashraf M, Baqai T, Choy E, Das D, Gullick N, Heighton C, Kinder A, Laxminarayan R, Mittal G, Morris P, Mukherjee S, Nandagudi A, Rangaraj S, Sharma P, Temple H, Traub B, Paisal V, Hum R, Vivekanantham A, Wilson R, Jadon D. Jethwa H, et al. Among authors: gullick n. Rheumatology (Oxford). 2025 May 1;64(5):3173-3176. doi: 10.1093/rheumatology/keaf037. Rheumatology (Oxford). 2025. PMID: 40037587 Free PMC article. No abstract available.
60 results